-
Live From New York: Zohran Mamdani’s Got Jokes
New York City’s next mayor showed during the campaign that he has a sharp sense of humor. Keeping things light at City Hall could be trickier.
-
Biden Warns of a ‘Very, Very Dark Moment’ as He Hits Out at Trump
The former president, now a far less popular figure in his party, appeared in Nebraska for an overtly political speech that slammed his successor.
-
Capturing Moments: How Smartphone Cameras Are Changing Photography Forever
When I was a kid, the idea of taking a picture meant waiting for special occasions. Birthdays, holidays, and family vacations were the big events that warranted the use of my parents’ chunky, heavy camera. Each click was precious because every roll of film had a limited number of shots. Fast forward a couple of…
-
Chalk Talk: Managing Threats from the Skies – A Critical Element of Stadium Security
In the next two years, the number of commercial and recreational drones operating in the United States is expected to almost triple, reaching close to three million. While the vast majority of drones are used for lawful business and hobbyist reasons, even negligent or accidental use can cause damage or harm….By: Venable LLP
-
AI-powered cyber threats: What everyone needs to know
A new report from Anthropic, a leading Artificial Intelligence (AI) company, highlights a troubling development in the cybersecurity landscape: threat actors are now using AI to automate nearly every step of a cyber extortion scheme. According to Anthropic, at least 17 companies were targeted in what they call the most comprehensive AI-driven cybercrime operation to…
-
New National Guidance Lays Out ‘Responsible Use of AI’ for Healthcare Industry
As artificial intelligence (AI) becomes increasingly embedded in processes and systems across healthcare organizations, clinicians and administrators face an intensifying challenge to adapt their organizations to the rapidly evolving AI environment….By: Parker Poe Adams & Bernstein LLP
-
Hikma Launches Ustekinumab Biosimilar STARJEMZA
On November 6, 2025, Hikma Pharmaceuticals PLC, and its subsidiary Hikma Pharmaceuticals USA Inc., announced the launch of STARJEMZA (ustekinumab-hmny). STARJEMZA references Janssen’s STELARA, and is indicated for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis….By: Goodwin
-
CMS Finalizes Changes to Bona Fide Service Fee Requirements, Alongside Other Adjustments to Medicare Part B Drug Reimbursement Methodology
On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) released its Final Rule for the Calendar Year (CY) 2026 Physician Fee Schedule (PFS), detailing significant updates to Medicare Part B payment policies. These changes will directly affect drug manufacturers’ government price reporting obligations and the calculation of Average Sales Price (ASP)….By: Goodwin
-
Order Granting Defendant Stephan Co’s Motion to Dismiss for Lack of Personal Jurisdiction
Court: Business and Consumer Court of Maine, Cumberland County – In this matter, Stephan Co. (“Stephan”) filed a motion to dismiss for lack of personal jurisdiction. The plaintiff, Jan Cuthbertson (“Plaintiff”), lives in Camden, Maine. Stephan is incorporated in and maintains its principal place of business in Florida, manufacturing, selling, and distributing hair care and…
-
As Saudi Arabia Cracks Down on Drugs, Executions Near a Record High
Facing an influx of amphetamines, the kingdom has put hundreds of people to death, many of them foreigners convicted of low-level smuggling.
